Adapthealth CORP Form 4 insider transactions

AdaptHealth Corp. Director David Solomon Williams III reported the sale of 5,000 shares of common stock at $9.43 per share, reducing his direct beneficial ownership to 45,045 shares.

AdaptHealth Corp. Director David S. Williams III sold 8,200 shares of common stock for a weighted average price of $9.73 per share on August 22, 2025.

AdaptHealth Corp. Director Theodore B. Lundberg reported the acquisition of 29,210 shares of common stock through equity awards, increasing his total beneficial ownership to 859,756 shares.

AdaptHealth Corp. Director Terence J. Connors acquired 21,346 shares of common stock, increasing his direct beneficial ownership to 76,263 shares.

AdaptHealth Corp. Director Susan T. Weaver reported the acquisition of 21,346 shares of common stock on June 26, 2025, increasing her direct beneficial ownership to 94,818 shares.

AdaptHealth Corp. Director Gregory Belinfanti reported the acquisition of 28,086 shares of common stock and the establishment of a Power of Attorney for future SEC filing compliance.

AdaptHealth Corp. Director Dale B. Wolf reported the acquisition of 21,346 shares of common stock at a price of $0, increasing his direct beneficial ownership to 96,235 shares, in addition to 14,000 shares held indirectly through a trust.

AdaptHealth Corp. Director David S. Williams III acquired 21,346 shares of common stock, increasing his beneficial ownership to 58,245 shares, as reported in a recent SEC Form 4 filing.

AdaptHealth Corp. Director Diana L. Nole reported the acquisition of 21,346 shares of common stock, increasing her direct beneficial ownership to 33,045 shares.

AdaptHealth Corp. Director Bradley J. Coppens is set to acquire 21,346 shares of common stock at a price of $0 on June 26, 2025, under a Rule 10b5-1(c) plan, increasing his beneficial ownership to 77,346 shares.

Russell E. Schuster III, Chief Commercial Officer of AdaptHealth Corp., reports the acquisition of common stock through restricted stock units.

Richard W. Rew II, CLO and General Counsel of AdaptHealth Corp., acquired 48,409 shares of common stock on February 1, 2025, as reported in a Form 4 filing with the SEC.

Albert Prast, Chief Technology Officer of AdaptHealth Corp., reports the acquisition of 62,932 restricted stock units, convertible to common stock, in a recent SEC filing.

Jason Clemens, CFO of AdaptHealth Corp., reports the acquisition of 125,863 shares of common stock and disposal of 546,582 shares.

Toby Scott Barnhart, Chief Operating Officer of AdaptHealth Corp., reports acquiring and disposing of common stock on February 1, 2025, according to a Form 4 filing.

Christine E. Archbold, Chief Accounting Officer of AdaptHealth Corp., reports the acquisition of 31,950 restricted stock units on February 1, 2025.

Suzanne Foster, CEO of AdaptHealth Corp., reports the acquisition of 271,090 shares and disposal of 594,601 shares of common stock on February 1, 2025.

AdaptHealth's Chief Financial Officer, Jason Clemens, sold 35,000 shares of company stock at an average price of $9.35.

AdaptHealth director Dale Wolf sold 7,000 shares of common stock at $10.80 per share on November 13, 2024.

Josh Parnes, a director at AdaptHealth Corp., amended the exercise period of his employee stock options, extending the deadline to March 31, 2025.

Director Diana L. Nole acquired 11,699 shares of AdaptHealth Corp. through restricted stock units on October 24, 2024.

Former AdaptHealth Corp. Chief Operating Officer Shaw Rietkerk sold 25,000 shares of common stock at an average price of $11.24 on September 20, 2024.

Toby Scott Barnhart, Chief Operating Officer of AdaptHealth Corp., acquired 89,392 restricted stock units that will be settled in common stock upon vesting.

Albert Prast, Chief Technology Officer of AdaptHealth Corp., reports the acquisition and disposition of common stock and derivative securities.

Director David Solomon Williams III of AdaptHealth Corp. [AHCO] recently sold shares of common stock in multiple transactions.

Gregory Belinfanti, a director at AdaptHealth Corp., reported the acquisition and disposal of common stock on June 24, 2024, according to a Form 4 filing with the SEC.

Director David S. Williams III reports acquisition and disposal of AdaptHealth Corp. common stock on June 24, 2024, according to a Form 4 filing.

Director Dale Wolf reports acquisition and disposal of AdaptHealth Corp. common stock on June 24, 2024.

Theodore B. Lundberg, a director of AdaptHealth Corp., reported the acquisition and disposal of common stock on June 24, 2024.

Terence Connors, a director at AdaptHealth Corp., reported the acquisition and disposal of common stock on June 24, 2024, according to a Form 4 filing with the SEC.